UCB | ||
|---|---|---|
OUTLOOK RATING 1..100 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | |
PROFIT vs RISK RATING 1..100 | 89 | |
SMR RATING 1..100 | 28 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 61 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DON | UCB | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 54% |
| Advances ODDS (%) | 2 days ago 81% | 2 days ago 57% |
| Declines ODDS (%) | 11 days ago 79% | 11 days ago 68% |
| BollingerBands ODDS (%) | 2 days ago 88% | 2 days ago 63% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 46% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 27.64 | 0.65 | +2.41% |
| Fidelity Disruptive Medicine ETF | |||
| HYLS | 40.67 | 0.01 | +0.02% |
| First Trust Tactical High Yield ETF | |||
| DDFL | 21.17 | N/A | +0.02% |
| Innovator Eq Dual Drctnl 15 Buf ETF -Jul | |||
| ADME | 54.73 | -0.02 | -0.04% |
| Aptus Drawdown Managed Equity ETF | |||
| UXJA | 37.21 | -0.03 | -0.09% |
| FT Vest U.S. Eq Uncppd Acceler ETF - Jan | |||
A.I.dvisor indicates that over the last year, UCB has been closely correlated with UBSI. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if UCB jumps, then UBSI could also see price increases.
| Ticker / NAME | Correlation To UCB | 1D Price Change % | ||
|---|---|---|---|---|
| UCB | 100% | +1.48% | ||
| UBSI - UCB | 91% Closely correlated | +1.08% | ||
| AUB - UCB | 90% Closely correlated | +2.11% | ||
| CATY - UCB | 90% Closely correlated | +0.57% | ||
| FULT - UCB | 89% Closely correlated | +1.76% | ||
| ASB - UCB | 88% Closely correlated | +1.58% | ||
More | ||||